Regeneron Pharma (REGN) PT Raised to $830 at RBC Capital
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $818.08 +1.51%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams raised the price target on Regeneron Pharma (NASDAQ: REGN) to $830.00 (from $820.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- iQIYI (IQ) PT Lowered to $1.10 at Morgan Stanley
- Femasys Inc. (FEMY) PT Lowered to $10 at Lake Street
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
